World Library  
Flag as Inappropriate
Email this Article

Meta-Tyramine

Article Id: WHEBN0026926702
Reproduction Date:

Title: Meta-Tyramine  
Author: World Heritage Encyclopedia
Language: English
Subject: Octopamine, Dopamine, Substituted phenethylamine, Thyronamine, 3-Methoxytyramine
Collection: Amines, Norepinephrine-Dopamine Releasing Agents, Phenethylamines, Phenols, Taar1 Agonists, Trace Amines
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Meta-Tyramine

meta-Tyramine
Identifiers
CAS number
PubChem
ChemSpider
Jmol-3D images Image 1
Properties
Molecular formula C8H11NO
Molar mass 137.18 g mol−1
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)

meta-Tyramine, also known as m-tyramine or 3-tyramine as well as 3-hydroxyphenylethylamine, is an endogenous monoamine compound and trace amine of the phenethylamine class.[1][2][3] It is a positional isomer of para-tyramine, and similarly to it, has effects on the adrenergic and dopaminergic systems.[4][5]

See also

References

  1. ^ Boulton AA, Huebert ND (November 1981). "Biosynthesis of some urinary trace amines in the rat and the human". Research Communications in Chemical Pathology and Pharmacology 34 (2): 295–310.  
  2. ^ Dyck LE, Juorio AV, Boulton AA (June 1982). "The in vitro release of endogenous m-tyramine, p-tyramine and dopamine from rat striatum". Neurochemical Research 7 (6): 705–16.  
  3. ^ Sardar A, Juorio AV, Boulton AA (June 1987). "The concentration of p- and m-tyramine in the rat mesolimbic system: its regional distribution and effect of monoamine oxidase inhibition". Brain Research 412 (2): 370–4.  
  4. ^ Dyck LE, Kazakoff CW, Dourish CT (October 1982). "The role of catecholamines, 5-hydroxytryptamine and m-tyramine in the behavioural effects of m-tyrosine in the rat". European Journal of Pharmacology 84 (3-4): 139–49.  
  5. ^ McQuade PS, Wood PL (1984). "The effects of administration of meta-tyramine and para-tyramine on dopamine and its metabolites in the rat striatum". Progress in Neuro-psychopharmacology & Biological Psychiatry 8 (4-6): 705–9.  


This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.